VELIN-PHARMA A/S: Financial statements 2018
CVR: 33026013
Source: annual report 2018, Danish Business Authority
01/06/2017 – 31/05/2018
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 85,588 and a net result of DKK -807,255 compared with DKK -147,228 the year before. That is a decrease of 47.8% compared with the year before. Equity in the 2018 report amounted to DKK 19,684,376. The solvency ratio was 99.1%.
- Gross Profit
- DKK 85,588
- Profit/Loss
- DKK -807,255
- Equity
- DKK 19,684,376
- Total Assets
- DKK 19,870,754
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 86 t. | -807 t. | 19.7 mio. | - |
| 2017 | - | 164 t. | -147 t. | 20.5 mio. | - |
| 2016 | - | 439 t. | 1.1 mio. | 20.6 mio. | - |
| 2015 | - | 518 t. | 1.7 mio. | 19.5 mio. | - |
| 2014 | - | 299 t. | 2 mio. | 17.8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.